Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations.

Stein BD, Bautista A, Schumock GT, Lee TA, Charbeneau JT, Lauderdale DS, Naureckas ET, Meltzer DO, Krishnan JA.

Chest. 2012 Jan;141(1):87-93. doi: 10.1378/chest.11-0024.

2.

Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how you count matters.

Stein BD, Charbeneau JT, Lee TA, Schumock GT, Lindenauer PK, Bautista A, Lauderdale DS, Naureckas ET, Krishnan JA.

COPD. 2010 Jun;7(3):164-71. doi: 10.3109/15412555.2010.481696.

PMID:
20486814
3.

Positive predictive value of ICD-9-CM codes to detect acute exacerbation of COPD in the emergency department.

Ginde AA, Tsai CL, Blanc PG, Camargo CA Jr.

Jt Comm J Qual Patient Saf. 2008 Nov;34(11):678-80.

PMID:
19025089
4.

Congestive heart failure in the United States: is there more than meets the I(CD code)? The Corpus Christi Heart Project.

Goff DC Jr, Pandey DK, Chan FA, Ortiz C, Nichaman MZ.

Arch Intern Med. 2000 Jan 24;160(2):197-202.

PMID:
10647758
5.

Coding algorithms for identifying patients with cirrhosis and hepatitis B or C virus using administrative data.

Niu B, Forde KA, Goldberg DS.

Pharmacoepidemiol Drug Saf. 2015 Jan;24(1):107-11. doi: 10.1002/pds.3721.

6.

Validation of ICD-9-CM codes to identify gastrointestinal perforation events in administrative claims data among hospitalized rheumatoid arthritis patients.

Curtis JR, Chen SY, Werther W, John A, Johnson DA.

Pharmacoepidemiol Drug Saf. 2011 Nov;20(11):1150-8. doi: 10.1002/pds.2215.

7.

Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection.

Schmiedeskamp M, Harpe S, Polk R, Oinonen M, Pakyz A.

Infect Control Hosp Epidemiol. 2009 Nov;30(11):1070-6. doi: 10.1086/606164.

PMID:
19803724
8.

Identifying pediatric community-acquired pneumonia hospitalizations: Accuracy of administrative billing codes.

Williams DJ, Shah SS, Myers A, Hall M, Auger K, Queen MA, Jerardi KE, McClain L, Wiggleton C, Tieder JS.

JAMA Pediatr. 2013 Sep;167(9):851-8.

9.

Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis.

Iwashyna TJ, Odden A, Rohde J, Bonham C, Kuhn L, Malani P, Chen L, Flanders S.

Med Care. 2014 Jun;52(6):e39-43. doi: 10.1097/MLR.0b013e318268ac86.

10.

Development and Validation of a Predictive Model to Identify Individuals Likely to Have Undiagnosed Chronic Obstructive Pulmonary Disease Using an Administrative Claims Database.

Moretz C, Zhou Y, Dhamane AD, Burslem K, Saverno K, Jain G, Devercelli G, Kaila S, Ellis JJ, Hernandez G, Renda A.

J Manag Care Spec Pharm. 2015 Dec;21(12):1149-59.

11.

Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.

Pasquale MK, Sun SX, Song F, Hartnett HJ, Stemkowski SA.

Int J Chron Obstruct Pulmon Dis. 2012;7:757-64. doi: 10.2147/COPD.S36997.

12.

Validation of an International Classification of Diseases, Ninth Revision Code Algorithm for Identifying Chiari Malformation Type 1 Surgery in Adults.

Greenberg JK, Ladner TR, Olsen MA, Shannon CN, Liu J, Yarbrough CK, Piccirillo JF, Wellons JC 3rd, Smyth MD, Park TS, Limbrick DD.

Neurosurgery. 2015 Aug;77(2):269-73. doi: 10.1227/NEU.0000000000000778.

13.

The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease.

Cooke CR, Joo MJ, Anderson SM, Lee TA, Udris EM, Johnson E, Au DH.

BMC Health Serv Res. 2011 Feb 16;11:37. doi: 10.1186/1472-6963-11-37.

14.

Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population.

Simoni-Wastila L, Yang HW, Blanchette CM, Zhao L, Qian J, Dalal AA.

Curr Med Res Opin. 2009 Nov;25(11):2729-35. doi: 10.1185/03007990903267157.

PMID:
19778165
15.

Validation of a coding algorithm to identify patients with hepatocellular carcinoma in an administrative database.

Goldberg DS, Lewis JD, Halpern SD, Weiner MG, Lo Re V 3rd.

Pharmacoepidemiol Drug Saf. 2013 Jan;22(1):103-7. doi: 10.1002/pds.3367.

16.

Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.

Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M.

J Manag Care Pharm. 2008 Mar;14(2):176-85.

17.

Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure.

Waikar SS, Wald R, Chertow GM, Curhan GC, Winkelmayer WC, Liangos O, Sosa MA, Jaber BL.

J Am Soc Nephrol. 2006 Jun;17(6):1688-94.

19.

Prevalence of unspecified sleep apnea and the use of continuous positive airway pressure in hospitalized patients, 2004 National Hospital Discharge Survey.

Spurr KF, Graven MA, Gilbert RW.

Sleep Breath. 2008 Aug;12(3):229-34. doi: 10.1007/s11325-007-0166-2.

PMID:
18236092
20.

The sex factor: epidemiology and management of chronic obstructive pulmonary disease in British Columbia.

Camp PG, Chaudhry M, Platt H, Roch M, Road J, Sin D, Levy RD.

Can Respir J. 2008 Nov-Dec;15(8):417-22.

Items per page

Supplemental Content

Support Center